Moffitt Cancer Center Showcases Research and Innovation at 13th Annual Business of Biotech Conference

February 19, 2019

TAMPA, Fla. — Artificial intelligence, cell therapy, clinical pathways and immune oncology production will be spotlighted at Moffitt Cancer Center’s 13th annual Business of Biotech Conference: Cracking the Cancer Code. The event, which brings together biomedical companies, startups, research organizations, entrepreneurs and investors, offers networking, collaboration and partnership opportunities. This year’s conference is from 8:30 a.m. to 3 p.m. Feb. 22 at Moffitt’s Vincent A. Stabile Research Building.

“Since 2006, the Business of Biotech Conference has been an opportunity for researchers, business professionals and investors to connect in the fight to discovering cures for cancer,” said Jarett Rieger, conference chairman and senior director of Moffitt’s Office of Innovation and Industry Alliances. “Each conference is a chance for the biotech community to network, learn from one another and invest in technological discoveries that may lead to cures of life-altering diseases.”

This year’s interview-style keynote address features Reid Huber, Ph.D. Huber is a partner at Third Rock Ventures, one of the industry’s preeminent venture capital firms. Prior to Third Rock, Huber was executive vice president and chief scientific officer at Incyte Corporation, where he helped to bring more than 25 therapeutics into clinical development. Huber has also held scientific research positions at DuPont Pharmaceuticals and Bristol-Myers Squibb.

“We are honored to have Dr. Huber as this year’s keynote address speaker,” said Rieger. “With his broad and extensive experience in drug discovery and clinical development, Dr. Huber has contributed to and led the discovery of two approved therapeutics, Jakafi® (ruxolitinib) and Olumiant® (baricitinib).”

Also during this year’s conference, Moffitt’s president and CEO will present the Moffitt Momentum Award to Hillsborough County Commissioner Sandy Murman. The award honors leaders who have championed Moffitt and cancer research.  Previous recipients of the award include Gov. Rick Scott and Tampa Mayor Bob Buckhorn.

About Moffitt Cancer Center
Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 49 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s scientific excellence, multidisciplinary research, and robust training and education. Moffitt is a Top 10 cancer hospital and has been nationally ranked by U.S. News & World Report since 1999. Moffitt devotes more than 2 million square feet to research and patient care. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 6,000 team members, Moffitt has an economic impact in the state of $2.1 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, Twitter and YouTube

###